Full history for every metric is available with a Kvantra account

Stock profile

China Chemical & Pharmaceutical Co., Ltd. (1701.TW)

Country: TaiwanSector: HealthcareIndustry: Drug Manufacturers - Specialty & GenericExchange: TAI

Delisted · last close 3 Sep 2024

Current price
21.15 TWD0.00%
Last close 3 Sep 2024
Benchmarks

Key financial summary

Financials in TWD
201820192020202120222023TTM
Total revenueTWD m7,5807,9708,1817,9498,4578,5758,871
Operating profitTWD m229372
Net profitTWD m370385557518478322355
EPS reportedTWD1.081.19
Operating cashflow per shareTWD0.810.81
Capex per shareTWD1.031.03
FCF per shareTWD-0.22-0.22
Free cash flowTWD m-67220
Net debtTWD m2,5932,299
Book value equityTWD m7,4327,402
Book value per shareTWD24.8924.82
Number of sharesm298.65298.24
DPS (TTM paid)TWD0.800.50

Financial summary

Financials in TWD
201820192020202120222023TTM
Value
P/E TTMx22.55-
P/B LTMx0.980.85
P/S LTMx0.850.71
P/FCF LTMx-108.9728.71
EV/EBITDA LTMx18.8811.03
EV/Sales LTMx1.200.97
Earnings Yield LTM%4.43%5.13%
FCF Yield%-0.92%3.48%
Quality
ROE%4.34%4.35%
ROIC%1.46%1.46%
Operating margin%2.67%2.67%
Gross margin%35.44%35.44%
FCF/Sales%-0.78%-0.78%
Growth and momentum
EPS Growth YoY%-32.08%-8.46%
Sales Growth YoY%+1.40%+3.17%
Net Income Growth YoY%-32.51%-8.20%
FCF Growth%--24.94%
Operating Profit Growth%-63.02%-26.51%
Dividend and capital structure
Dividend Yield%3.28%2.36%
Dividend Growth%-11.11%-
Payout Ratio%73.99%66.96%
FCF/Debtx-0.020.07
Net Debt/EBITDAx5.515.51
EBIT/Net interestx3.853.85
Net debt/market cap%35.67%36.47%
Net debt/Equityx0.350.31
Gross debt/equityx0.460.42

Company overview

China Chemical & Pharmaceutical Co., Ltd. (CCP), established in Taipei, Taiwan, in 1952, is a prominent player in the pharmaceutical sector. The company specializes in the research, development, manufacturing, and distribution of generic pharmaceutical and healthcare products, serving both human and animal health markets. Its extensive human pharmaceutical portfolio encompasses a wide array of therapeutic areas. Key offerings include medications for cardiovascular health (such as treatments for heart conditions, cholesterol management, and peripheral circulation disorders), metabolic conditions (including diabetes, weight management, and corticosteroid therapies), and infectious diseases (like antibiotics, antifungals, and antivirals). CCP also provides a range of nutritional supplements, from vitamins and hepatic support agents to electrolyte and caloric preparations. Other significant categories cover pain and inflammation relief (antipyretics, analgesics, anti-inflammatories), digestive system remedies (gastrointestinal drugs, gut health enhancers, antispasmodics), and respiratory treatments (antitussives, antihistamines, and asthma medications). Furthermore, the company produces drugs addressing urological issues (specifically for benign prostatic hyperplasia), central nervous system disorders (hypnotics, mood stabilizers, and antidepressants), and critical areas like hematology and oncology, alongside other general preparations and sexual well-being products. Beyond prescription medications, CCP's non-prescription (OTC) division offers popular consumer health products, such as vitamins, topical skincare items, cold and cough remedies, anti-inflammatory pain relievers, and digestive aids. The company additionally supplies antibacterial and disinfectant solutions. In the animal health sector, CCP manufactures veterinary pharmaceuticals catering to livestock (pigs and cattle), poultry, and companion animals, alongside various feed supplements. Rounding out its operations, China Chemical & Pharmaceutical Co., Ltd. offers contract manufacturing services to other industry players.

WebsiteN/A
IndustryDrug Manufacturers - Specialty & Generic
CountryTaiwan
Trades inTWD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 3 Sep 2024

China Chemical & Pharmaceutical Co., Ltd. (1701.TW)

1701.TW · TAI · Healthcare
21.15 TWD0.00%
Benchmarks
Financialsin TWD
20222023TTM
About

China Chemical & Pharmaceutical Co., Ltd. (CCP), established in Taipei, Taiwan, in 1952, is a prominent player in the pharmaceutical sector. The company specializes in the research, development, manufacturing, and distribution of generic pharmaceutical and healthcare products, serving both human and animal health markets. Its extensive human pharmaceutical portfolio encompasses a wide array of therapeutic areas. Key offerings include medications for cardiovascular health (such as treatments for heart conditions, cholesterol management, and peripheral circulation disorders), metabolic conditions (including diabetes, weight management, and corticosteroid therapies), and infectious diseases (like antibiotics, antifungals, and antivirals). CCP also provides a range of nutritional supplements, from vitamins and hepatic support agents to electrolyte and caloric preparations. Other significant categories cover pain and inflammation relief (antipyretics, analgesics, anti-inflammatories), digestive system remedies (gastrointestinal drugs, gut health enhancers, antispasmodics), and respiratory treatments (antitussives, antihistamines, and asthma medications). Furthermore, the company produces drugs addressing urological issues (specifically for benign prostatic hyperplasia), central nervous system disorders (hypnotics, mood stabilizers, and antidepressants), and critical areas like hematology and oncology, alongside other general preparations and sexual well-being products. Beyond prescription medications, CCP's non-prescription (OTC) division offers popular consumer health products, such as vitamins, topical skincare items, cold and cough remedies, anti-inflammatory pain relievers, and digestive aids. The company additionally supplies antibacterial and disinfectant solutions. In the animal health sector, CCP manufactures veterinary pharmaceuticals catering to livestock (pigs and cattle), poultry, and companion animals, alongside various feed supplements. Rounding out its operations, China Chemical & Pharmaceutical Co., Ltd. offers contract manufacturing services to other industry players.

IndustryDrug Manufacturers - Specialty & Generic
CountryTaiwan
Trades inTWD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free